EMIG (Ethical Medicines Industry Group) Chair, Leslie Galloway, tells @BBCRadio4 that leaving the EMA could mean patients are forced to wait for life-saving medicines and may miss out on important clinical trials.
Concerned? Share this ↓
Almost 2 years since I successfully passed a European Medicines Agency amendment to the then Trade Bill. Its primary purpose was to help the UK avoid medicine supply problems post Brexit. Look where we are now. Don’t recall “drug supply difficulties” being on the side of that bus
Today, EMA staff lowered the 28 EU flags and symbolically said goodbye to their London offices. Guido Rasi expressed his thanks to the UK for its contribution to the work of the Agency and for having been a gracious host of EMA since 1995.
Doctors who care about the future of the NHS can see the damage that Brexit is already doing - and GPs have today called for a #peoplesvote on the final deal.
Christmas is coming.
The PM's Brexit wish list to Santa will leave NHS patients with no guarantees that they'll keep the benefits of being members of the European Medicines Agency. #politicaldeclaration@peoplesvote_uk
It is therefore the duty of all MPs to put their political allegiances aside and vote against this deal - for the good of patients.
Please share this post.
Parliament passed an amendment to the EU Withdrawal Act to keep the U.K. in the European Medicines Agency. The political declaration states that “the Parties will also explore the possibility of cooperation”. Parliament ignored again. So much for taking back control.
Not being part of the European Medicines Agency will push the UK to the back of the queue for new medical drugs, including those currently in development for treating #HIV.
#Brexit is a disaster. Support a #PeoplesVote to #StopBrexit.
@vickyford If the UK is forced to undergo a separate approvals process, patients like Simon Lamont Brown will die needlessly, and that's before we consider what could be an even lengthier reimbursement process if UK GDP shrinks.
https://t.co/FaPGO28wPQ